⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6763348 | 0.97 | LMNA (0.37) | — | |
| Water SCHEMBL7929821 | 0.97 | LMNA (0.37) | — | |
| Water SCHEMBL5127632 | 0.97 | LMNA (0.37) | — | |
| Trifluoroacetic Acid SCHEMBL630048 | 0.91 | LMNA (0.40) | — | |
| SCHEMBL7211526 | 0.81 | EPHX1 (0.31) | — | |
| SCHEMBL7934605 | 0.78 | — | — | |
| SCHEMBL5860710 | 0.78 | — | — | |
| SCHEMBL6908016 | 0.78 | — | — | |
| SCHEMBL11635042 | 0.75 | — | — | |
| SCHEMBL6510412 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332040-A1 | SUBSTITUTED 4-AMINO-1H-IMIDAZO[4,5-c]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION | INNATE TUMOR IMMUNITY INC (US) | 2021-10-28 | — | — | US | claimed |
| EP-3837245-A1 | SUBSTITUED 4-AMINO-1H-IMIDAZO[4,5-C]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION | Innate Tumor Immunity, Inc. (US) | 2021-06-23 | — | — | EP | claimed |
| WO-2020037094-A1 | SUBSTITUED 4-AMINO-1H-IMIDAZO[4,5-C]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION | INNATE TUMOR IMMUNITY, INC. (US) | 2020-02-20 | — | — | WO | claimed |
| US-7002043-B2 | Process for producing 1,1,1-trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2006-02-21 | — | — | US | claimed |
| EP-1127865-B1 | Process for producing 1,1,1-Trifluoroacetone | CENTRAL GLASS CO LTD (JP) | 2005-11-02 | — | — | EP | claimed |
| US-20040034254-A1 | Process for producing 1,1,1-trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2004-02-19 | — | — | US | claimed |
| US-6340776-B2 | HYROGENOLYSIS OF HALOGENATED TRIFLUOROACETONE BY HYDROGEN GAS IN PRESENCE OF TRANSITION METAL CATALYST | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-01-22 | — | — | US | claimed |
| US-20010037041-A1 | Process for producing 1,1,1,-trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-11-01 | — | — | US | claimed |
| EP-1127865-A1 | Process for producing 1,1,1-Trifluoroacetone | Central Glass Company, Limited (JP) | 2001-08-29 | — | — | EP | claimed |
| EP-0872468-B1 | Method for producing 3,3-dichloro-1,1,1-trifluoroacetone | CENTRAL GLASS CO LTD (JP) | 2001-07-25 | — | — | EP | claimed |
| US-6177595-B1 | FLUORINATING IN A LIQUID PHASE A 1,1-DICHLORO-3-FLUORO-3,3-DICHLORO-, CHLORO/FLUORO-, OR DIFLUOROACETONE, PREFERABLY PENTACHLOROACETONE, BY HYDROGEN FLUORIDE USING A CATALYST OF TIN TETRAHALIDE; CORROSION RESISTANCE; EFFICIENCY | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-01-23 | — | — | US | claimed |
| US-5905174-A | FLUORINATING PENTACHLOROACETONE WITH HYDROGEN FLUORIDE IN THE PRESENCE OF A CATALYST | CENTRAL GLASS COMPANY, LIMITED (JP) | 1999-05-18 | — | — | US | claimed |
| EP-0872468-A1 | Method for producing 3,3-dichloro-1,1,1-trifluoroacetone | Central Glass Company, Limited (JP) | 1998-10-21 | — | — | EP | claimed |
| JP-11001451-A | — | — | None | — | — | JP | disclosed |
| JP-11001451-A | — | — | None | — | — | JP | disclosed |
| JP-9227440-A | — | — | None | — | — | JP | disclosed |
| US-4704450-A | OLIGO- AND POLYPEPTIDES | SANOFI (FR) | 1987-11-03 | — | — | US | disclosed |
| US-4581168-A | COUPLING OF PEPTIDES, THEN HYDROLYSIS | SANOFI (FR) | 1986-04-08 | — | — | US | disclosed |
| US-4426324-A | Immunopotentiating peptides | HOFFMANN-LA ROCHE INC. (US) | 1984-01-17 | — | — | US | disclosed |
| US-4247543-A | OLIGOPEPTIDES; ANALGESICS; NERVOUS SYSTEM DISORDERS | SANDOZ LTD. (CH) | 1981-01-27 | — | — | US | disclosed |